Literature DB >> 18639337

Early renal arterial stent thrombosis associated with the JAK2 V617F mutation.

Piotr Tabaczewski, Suhasini Nadesan, Seah H Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18639337      PMCID： PMC2695997          DOI： 10.1016/j.leukres.2008.06.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  8 in total

1.  Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis.

Authors:  Fernando Alfonso; Alfonso Suárez; María J Pérez-Vizcayno; Raul Moreno; Javier Escaned; Camino Bañuelos; Pilar Jiménez; Esther Bernardo; Dominick J Angiolillo; Rosana Hernández; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

2.  JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.

Authors:  A Pardanani; T L Lasho; S Schwager; C Finke; K Hussein; R K Pruthi; A Tefferi
Journal:  Leukemia       Date:  2007-04-26       Impact factor: 11.528

3.  Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.

Authors:  V De Stefano; A Fiorini; E Rossi; T Za; G Farina; P Chiusolo; S Sica; G Leone
Journal:  J Thromb Haemost       Date:  2007-01-29       Impact factor: 5.824

4.  Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome.

Authors:  I Moussa; C Di Mario; B Reimers; T Akiyama; J Tobis; A Colombo
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

5.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

6.  Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.

Authors:  Paul Wexberg; Nelli Jordanova; Christoph Strehblow; Bonni Syeda; Brigitte Meyer; Silvia Charvat; Gerlinde Zorn; Daniela Scheinig; Johann Wojta; Kurt Huber; Dietmar Glogar; Mariann Gyöngyösi
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

Review 7.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Authors:  Christoph Stettler; Simon Wandel; Sabin Allemann; Adnan Kastrati; Marie Claude Morice; Albert Schömig; Matthias E Pfisterer; Gregg W Stone; Martin B Leon; José Suarez de Lezo; Jean-Jacques Goy; Seung-Jung Park; Manel Sabaté; Maarten J Suttorp; Henning Kelbaek; Christian Spaulding; Maurizio Menichelli; Paul Vermeersch; Maurits T Dirksen; Pavel Cervinka; Anna Sonia Petronio; Alain J Nordmann; Peter Diem; Bernhard Meier; Marcel Zwahlen; Stephan Reichenbach; Sven Trelle; Stephan Windecker; Peter Jüni
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321

Review 8.  Malignancy: an unrecognized risk factor for coronary stent thrombosis?

Authors:  Alex R Hobson; Daniel B McKenzie; Vijayalakshmi Kunadian; Ian Purcell; Azfar Zaman; Keith D Dawkins; Nick Curzen
Journal:  J Invasive Cardiol       Date:  2008-04       Impact factor: 2.022
  8 in total
  2 in total

Review 1.  Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.

Authors:  Eikan Mishima; Takehiro Suzuki; Yoichi Takeuchi; Kazumasa Seiji; Noriko Fukuhara; Kei Takase; Hideo Harigae; Takaaki Abe; Sadayoshi Ito
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738

2.  Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

Authors:  Kouichi Tamura; Kotaro Haruhara; Kengo Azushima; Tamio Iwamoto; Hiromichi Wakui
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.